Toxina botulínica, rompiendo el paradigma en el abordaje por dermatología, cirugía plástica y neurología
Palabras clave:
Toxina botulínica, cirugía plástica, dermatología, pediatría, indicaciones no aprobadas, neurología.Resumen
La toxina botulínica ha tenido un papel fundamental en el tratamiento de diferentes condiciones médicas incluso previo a su uso como uno de los principales componentes de la medicina plástica y reconstructiva, así como de sus múltiples aplicaciones dermatológicas. Evidenciamos como se ha implementado en diferentes condiciones médicas tales como manejo de dolor, condiciones neurológicas, urológicas y oftalmológicas, así como rehabilitación de pacientes. Buscamos exponer un panorama amplio de posibilidades de manejo con la toxina botulínica fuera de su papel protagónico en la medicina estética.
Citas
Alster TS, HarrisonIS. Alternative Clinical Indications of Botulinum Toxin. American Journal of Clinical Dermatology. Adis; 2020;21:855–80.
Freeman M, Margulies I. Nonaesthetic Applications for Botulinum Toxin in Plastic Surgery. Plast Reconstr Surg. Julio de 2020;157–70.
Tian K. A study of combination unilateral subcutaneous botulinum toxin a treatment for androgenetic alopecia. J Cosmet Dermatol. 2022;21(11):5584
Carloni R, Pechevy L, Postel F, Zielinski M, Gandolfi S. Is there a therapeutic effect of botulinum toxin on scalp alopecia? Physiopathology and reported cases: A systematic review of the literature. Journal of Plastic, Reconstructive and Aesthetic Surgery. Churchill Livingstone. 2020;73:2210
Grimstad Ø, Kvammen BØ, Swartling C. Botulinum Toxin Type B for Hidradenitis Suppurativa: A Randomised, Double-Blind, Placebo-Controlled Pilot Study. Am J Clin Dermatol. 2020;21(5):741–8.
Gallegos JE, Inglesby DC, Young ZT, Herrera FA. Botulinum Toxin for the Treatment of Intractable Raynaud Phenomenon. Journal of Hand Surgery. W.B. Saunders. 2021;46:54–9.
Lautenbach G, Dobrota R, Mihai C, Distler O, Calcagni M, Maurer B. Evaluation of botulinum toxin A injections for the treatment of refractory chronic digital ulcers in patients with systemic sclerosis. Clin Exp Rheumatol. 2020;38 Suppl 125(3):154–60.
Jurairattanaporn N, Palakornkitti P, Anuntrangsee T, Vachiramon V. Study of botulinum toxin type A for the treatment of ultraviolet B‐induced hyperpigmentation: A prospective, randomized, controlled trial. J Cosmet Dermatol. 2022;21(8):3343–50.
Shuo L, Ting Y, KeLun W, Rui Z, Rui Z, Hang W. Efficacy and possible mechanisms of botulinum toxin treatment of oily skin. Vol. 18, Journal of Cosmetic Dermatology. Blackwell Publishing Ltd; 2019;451–7.
Park JY, Cho SI, Hur K, Lee DH. IncobotulinumtoxinA injection for sebum control, face lifting, and pore improvement. Toxicon. 2021;190:S56–7.
Rasaii S, Sohrabian N, Gianfaldoni S, Hadibarhaghtalab M, Pazyar N, Bakhshaeekia A, et al. Intralesional triamcinolone alone or in combination with botulinium toxin A is ineffective for the treatment of formed keloid scar: A double blind controlled pilot study. Dermatol Ther. 2019;32(2).
Bi M, Sun P, Li D, Dong Z, Chen Z. Intralesional injection of botulinum toxin type a compared with intralesional injectionof corticosteroid for the treatment of hypertrophic scar and keloid: A systematic review and meta-analysis. Medical Science Monitor. 2019;25:2950–8.
Liu X, Zhang D. Evaluation of Efficacy of Corticosteroid and Corticosteroid Combined with Botulinum Toxin Type A in the Treatment of Keloid and Hypertrophic Scars: A Meta-Analysis. Aesthetic Plastic Surgery. Springer; 2021;45:3037–44.
Heikel T, Patel S, Ziai K, Shah SJ, Lighthall JG. Botulinum Toxin A in the Management of Pediatric Sialorrhea: A Systematic Review. Annals of Otology, Rhinology and Laryngology. SAGE Publications Inc. 2023;132:200
Delsing CPA, Bekkers S, Erasmus CE, van Hulst K, van den Hoogen FJA. Posterior drooling in children with cerebral palsy and other neurodevelopmental disorders. Dev Med Child Neurol. 2021;63(9):1093–8.
Obed D, Salim M, Bingoel AS, Hofmann TR, Vogt PM, Krezdorn N. Botulinum Toxin Versus Placebo: A Meta-Analysis of Treatment and Quality-of-life Outcomes for Hyperhidrosis. Aesthetic Plast Surg. 2021;45(4):1783–91.
Wu CJ, Chang CK, Wang CY, Liao YS, Chen SG. Efficacy and Safety of Botulinum Toxin A in Axillary Bromhidrosis and Associated Histological Changes in Sweat Glands: A Prospective Randomized Double-Blind Side-by-Side Comparison Clinical Study. Dermatologic Surgery. 2019;45(12):1605–9.
Asfour L, Moussa A, Littlewood Z, Sharif J, Newsham J, O’Donoghue N, et al. Botulinum toxin A injections in the treatment of axillary hyperhidrosis: a prospective study reviewing quality of life and patient satisfaction in a UK tertiary dermatology centre. Clinical and Experimental Dermatology. John Wiley and Sons Inc. 2022;47:1358–9.
Lynch O. Five year Follow Up of Patients Treated with Regular Intradermal Botulinum Toxin Type A for Management of Axillary Hyperhidrosis. European Journal of vascular y endovascular surgery. 2020;60(2):56–7.
Chen W, Zhang X, Zhang L, Xu Y. Treatment of axillary bromhidrosis in adolescents by combining electrocauterization with ultrasound-guided botulinum toxin type A injection. Journal of Plastic, Reconstructive and Aesthetic Surgery. 2021;74(11):3114–9.
Campanati A, Gregoriou S, Consales V, Rizzetto G, Bobyr I, Diotallevi F, et al. Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study. Dermatol Ther. 2020;33(6).
Cabreus P, Swartling C, Rystedt A. Postmenopausal craniofacial hyperhidrosis treated with botulinum toxin type B. Journal of Dermatology. 2019;46(10):874–8.
Fu Z, Huang H, Huang J. Efficacy and safety of botulinum toxin type A for postoperative scar prevention and wound healing improvement: A systematic review and meta‐analysis. J Cosmet Dermatol. 2022;21(1):176
Hu L, Zou Y, Chang SJ, Qiu Y, Chen H, Gang M, et al. Effects of botulinum toxin on improving facial surgical scars: A prospective, split-scar, double-blind, randomized controlled trial. Plast Reconstr Surg. 2018;141(3):646–50.
Qiao Z, Yang H, Jin L, Li S, Wang X. The Efficacy and Safety of Botulinum Toxin Injections in Preventing Postoperative Scars and Improving Scar Quality: A Systematic Review and Meta-Analysis. Aesthetic Plastic Surgery. Springer; 2021;45:2350–62.
Wang W, Liu G, Li X. The Efficacy and Safety of Botulinum Toxin Type A Injections in Improving Facial Scars: A Systematic Review and Meta-Analysis. Pharmacology. S. Karger AG; 2022.
Lin MJ, Bernstein DM, Torbeck RL, Dubin DP, Rosenberg JD, Khorasani H. Botulinum toxin improves forehead scars after Mohs surgery: A randomized, double-blinded, controlled study. J Am Acad Dermatol. 2022;86(4):964–6.
Wang Y, Wang J, Zhang J, Hu C, Zhu F. Effectiveness and Safety of Botulinum Toxin Type A Injection for Scar Prevention: A Systematic Review and Meta-analysis. Aesthetic Plast Surg. 2019;43(5):1241–9.
Zhang W, Li X, Li X. Efficacy and Safety of Botulinum Toxin Type A in Preventing Postoperative Scars and Improving the Cosmetic Appearance of Scars: A Systematic Review and Meta-Analysis. J Cutan Med Surg. 2020;24(6):608–18.
Kim SH, Lee SJ, Lee JW, Jeong HS, Suh IS, Aiempanakit K. Clinical trial to evaluate the efficacy of botulinum toxin type A injection for reducing scars in patients with forehead laceration: A double-blinded, randomized controlled study. Medicine. Lippincott Williams and Wilkins; 2019.
Hassan AM, Chappell AG, Boyd RM, Joshi C, Wan R, Carabano M, et al. The Use of Botulinum Toxin to Prevent Anastomotic Thrombosis and Promote Flap Survival. Ann Plast Surg. 2021;87(2):222–9.
Olla D, Sawyer J, Sommer N, Moore JB. Migraine Treatment. Clinics in Plastic Surgery. W.B. Saunders; 2020;47:295–303.
Bruloy E, Sinna R, Grolleau JL, Bout-Roumazeilles A, Berard E, Chaput B. Botulinum toxin versus placebo: A meta- analysis of prophylactic treatment for migraine. Plast Reconstr Surg. 2019;143(1):239–50.
Santana L. Experiencia de las inyecciones de toxina botulínica a para la migraña crónica en una clínica de dolor crónico pediátrico. Revista de farmacología y terapéutica pediátrica. 2021;26:151–6.
Li X, Feng X, Li J, Bao X, Xu J, Lin J. Can Botulinum Toxin-A Contribute to Reconstructing the Physiological Homeostasis of the Masticatory Complex in Short-faced Patients during Occlusal Therapy? A Prospective Pilot Study. Toxins. 2022;14(6).
Altaweel AA, Elsayed SAH, Baiomy AABA, Abdelsadek SE, Hyder AA. Extraoral Versus Intraoral Botulinum Toxin Type A Injection for Management of Temporomandibular Joint Disc Displacement with Reduction. Journal of Craniofacial Surgery. 2019;30(7):2149–53.
Shome D, Khare S, Kapoor R. Efficacy of Botulinum Toxin in Treating Asian Indian Patients with Masseter Hypertrophy: A 4-Year Follow-Up Study. Plast Reconstr Surg. 2019;144(3):390e–6e.
Paulson A, Zigler CK, Houtrow A, Pruitt D. Botulinum Toxin: Techniques Within Pediatric Physiatry. PM and R. 2019;11(1):38–44.
Sobti A, Magill N, Norman-Taylor F. G75(P) Preoperative botulinum toxin a for children with bilateral cerebral palsy undergoing major hip surgery: a randomised double-blind placebo-controlled trial with 6 months follow-up. Arch Dis Child. 2020;105(Suppl 1):A23. Disponible en: http://adc.bmj.com/content/105/Suppl_1/A23.1.abstract
Hehr JD, Schoenbrunner AR, Janis JE. The use of botulinum toxin in pain management: Basic science and clinical applications. Plast Reconstr Surg. 2020;629E-636E.
Rayess YA, Awaida CJ, Jabbour SF, Ballan AS, Sleilati FH, Abou Zeid SM, et al. Botulinum toxin for benign essential blepharospasm: A systematic review and an algorithmic approach. Rev Neurol. 2021;177(1–2):107–14.
Landau M, Nestor MS, de Almeida AT, Al-Niaimi F. Botulinum toxin complications in registered and off-label aesthetic indications. Journal of Cosmetic Dermatology. Blackwell Publishing Ltd; 2020;19:2484–90.
Descargas
Publicado
Versiones
- 2025-11-21 (4)
- 2025-11-21 (3)
- 2025-08-18 (2)
- 2023-09-04 (1)
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Scientific and Eduaction Medical JournalAtribución – No comercial – Compartir igual: Esta licencia permite a otros distribuir, remezclar, retocar, y crear a partir de tu obra de modo no comercial, siempre y cuando te den crédito y licencien sus nuevas creaciones bajo las mismas condiciones.
Attribution-NonCommercial-ShareAlike 4.0 International
